savient pharmaceuticals inc

Rightnow Technologies (Nasdaq: RNOW) 7.4% HIGHER; after mysteriously plunging about 12% just minutes before today's close, the stock has climbed back in the after-hours session.

Not hearing any news out of the company. Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) 1% LOWER; announced that their Board has formally initiated a search for a new Chief Executive Officer.

To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.

Astea International Inc. (Nasdaq: ATEA) 78.4% HIGHER; announced that their Alliance solution has been selected by a leading telecom network solutions provider to automate, mobilize and optimize their global field service operations.

The Wilber Corporation (AMEX: GIW) 50.3% HIGHER; Community Bank System, Inc. (NYSE: CBU) and Wilber announced that they have entered into an agreement whereby Community Bank will acquire The Wilber Corporation for $101.8 million in Community Bank System stock and cash, or $9.50 per share.

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High:

• Savient Pharmaceuticals, Inc.
  
  (Nasdaq: SVNT) high of $19.95. Soaring over 35% to its new high today, investors are buying into SVNT as the U.S.
  
  FDA approved its krystexxa for the treatment of gout. Some see a buyout next.
• Airgas Inc. (NYSE: ARG) high of $67.63.

Star Scientific, Inc. (Nasdaq: STSI) 76.4% LOWER; R.J. Reynolds Tobacco Company (NYSE: RAI) today announced a jury verdict in favor of the company in a patent infringement lawsuit brought by Star Scientific in the U.S.

District Court for Maryland - Northern Division. Click here for the full report.

Savient Pharmaceuticals, Inc.

Star Scientific (Nasdaq: STSI) 65.4% LOWER; RJ Reynolds wins a verdict in the Star Tobacco patent trial. Merix Corporation (NASDAQ: MERX) 43.2% HIGHER; announced a major, multi-million dollar order from global avionics and communications pioneer Rockwell Collins (NYSE: COL).

The order is a direct result of Merix's focus on the defense and aerospace sector where the company has broadened its product offering and grown its market share in the past 14 months.

Savient Pharmaceuticals, Inc.